JMP analyst upgrades Affirm Holdings to Market Outperform, citing long-term potential in buy now, pay later solutions and ...

Alliance Global Partners downgraded shares of Innovative Industrial Properties (NYSE:IIPR – Free Report) from a strong-buy ...

Analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Enanta Pharmaceuticals in a ...

Fintel reports that on December 20, 2024, JMP Securities upgraded their outlook for Affirm Holdings (NasdaqGS:AFRM) from ...

Investing.com -- JMP upgraded Affirm Holdings Inc (NASDAQ:AFRM) to "market outperform" from "market perform," on the buy-now-pay-later firm's strong positioning and improved profitability outlook.

JMP Securities analyst Aaron Kimson maintained a Buy rating on nCino (NCNO – Research Report) today and set a price target of $43.00. The ...

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Larimar Therapeutics (LRMR – Research Report) yesterday and set a price ...

Wells Fargo has recently initiated Savara Inc (SVRA) stock to Overweight rating, as announced on December 20, 2024, according to Finviz. Earlier, on November 13, 2024, Evercore ISI had reduced the ...

JMP Securities upgrades from 'market perform' to 'market outperform,' noting its strong hold in the growing adoption of their buy now, pay later strategy. The expense offers a competitive advantage ...

On Tuesday, Syros Pharmaceuticals Inc (SYRS) stock saw a modest uptick, ending the day at $0.2 which represents no change from the prior close of of $0.2. The stock opened at $0.2 and touched a low of ...

JMP analyst David Scharf upgraded Affirm Holdings (NASDAQ:AFRM) shares to Market Outperform from Market Perform on Friday, calling it a "long-term secular winner at the expense primarily of the ...